Search filters

List of works by Martin Bauer

A PET microdosing study with the P-glycoprotein inhibitor tariquidar

A Prediction Method for P-glycoprotein-Mediated Drug-Drug Interactions at the Human Blood-Brain Barrier From Blood Concentration-Time Profiles, Validated With PET Data.

scientific article

A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier

scientific article published on 20 September 2018

A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.

scientific article published on February 2011

A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of C- and C-labelled verapamil in healthy volunteers

A double-blind, randomized clinical study to determine the efficacy of benzocaine 10% on histamine-induced pruritus and UVB-light induced slight sunburn pain.

scientific article published on 11 February 2015

A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET

scientific article published on 12 November 2009

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease

scientific article published in September 2006

Acute HIV Infection Results in Subclinical Inflammatory Cardiomyopathy.

scientific article

Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET

scientific article published on 24 October 2018

Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.

scientific article published on 05 August 2009

Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study.

scientific article published on 11 February 2015

Assessment of P-Glycoprotein Transport Activity at the Human Blood-Retina Barrier with (R)-11C-Verapamil PET.

scientific article published on 13 October 2016

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography

scientific article published on 12 December 2019

Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier.

scientific article published on 16 December 2009

Blood-brain barrier P-glycoprotein function in Alzheimer's disease

scientific article published on 26 November 2011

Continuous femoral nerve blocks: decreasing local anesthetic concentration to minimize quadriceps femoris weakness

scientific article published on March 2012

Decreased blood-brain barrier P-glycoprotein function with aging

scientific article published on 5 November 2008

Disposition and metabolism of ralfinamide, a novel Na-channel blocker, in healthy male volunteers.

scientific article published on 11 November 2010

Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[11C]verapamil PET.

scientific article

Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects.

scientific article published on 12 April 2017

Effect of Rifampicin on the Distribution of [11C]Erlotinib to the Liver, a Translational PET Study in Humans and in Mice

scientific article published on 14 September 2018

Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia

scientific article published on 22 February 2017

Imaging P-Glycoprotein Function at the Blood-Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs

scientific article published on 23 March 2019

Imaging P-glycoprotein Induction at the Blood-Brain Barrier of a Beta-Amyloidosis Mouse Model with 11C-Metoclopramide PET

scientific article published on 05 December 2019

Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans

scientific article published on 10 January 2019

Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats

scientific article published on 16 August 2018

In vivo P-glycoprotein function before and after epilepsy surgery.

scientific article

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

scientific article published on 22 September 2017

Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [11C]erlotinib

scientific article published on 11 February 2019

Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier

scientific article published on 5 July 2013

Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence

scientific article published on January 2012

Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease

scientific article published on 13 February 2009

Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe ×PS1Δe9 transgenic mouse model of Alzheimer's disease

scientific article published on 10 November 2017

Making Sense of: Sensitization in Schizophrenia

scientific article

Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [11C]Tariquidar and PET in Humans and Mice

scientific article published on 17 December 2019

P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of 11C-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman Primates

scientific article published on 10 May 2018

P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study

scientific article published on 18 June 2013

PM478. Imaging the effects of d-amphetamine in the human brain for modelling dopaminergic alterations in schizophrenia

scientific article published on 27 May 2016

Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients

scientific article published on 11 September 2007

Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data

scientific article

Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs

scientific article published on 04 October 2019

Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography

scientific article

Pharmacokinetics of single ascending doses of the P-glycoprotein inhibitor tariquidar in healthy subjects

scientific article published on 7 November 2012

Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration

scientific article published on 01 October 2018

Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil

scientific article

Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain Barrier

scientific article published on 03 March 2016

Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism

scientific article published on 02 August 2019

Psyche at the end of life: Psychiatric symptoms are prevalent in patients admitted to a palliative care unit.

scientific article published on 8 October 2015

Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers.

scientific article

Reproducibility of Quantitative Brain Imaging Using a PET-Only and a Combined PET/MR System.

scientific article

Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.

scientific article

Synthesis of a [18F]fluorobenzothiazole as potential amyloid imaging agent

Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography

scientific article published on 29 April 2019

Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues

scientific article published on 28 March 2014

Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans.

scientific article

[11C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans.

scientific article published on 5 September 2011